4′-fluoro nucleosides for the treatment of HCV

BA Mayes, AM Moussa, AJ Stewart… - US Patent …, 2015 - Google Patents
Provided herein are compounds, compositions and methods for the treatment of Flaviviridae
infections, including HCV infections. In certain embodiments, compounds and compo sitions …

3′, 5′-cyclic phosphoramidate prodrugs for HCV infection

CC Parsy, FR Alexandre, CB Dousson… - US Patent …, 2015 - Google Patents
(*) Notice: Subject to any disclaimer, the term of this 7,192,936 B2 3/2007 LaColla et al.
patent is extended or adjusted under 35 7,202,224 B2 4/2007 Eldrup et al. USC 154 (b) by 0 …

2′, 4′-fluoro nucleosides for the treatment of HCV

BA Mayes, AM Moussa, AJ Stewart - US Patent 9,187,515, 2015 - Google Patents
Provided herein are compounds, methods and pharmaceuti cal compositions for use in
treatment of viral infections, including hepatitis C virus (HCV) infections, in hosts in need …

Esters and malonates of SATE prodrugs

BA Mayes, AM Moussa - US Patent 9,192,621, 2015 - Google Patents
Provided herein are compounds, compositions and methods for the treatment of Flaviviridae
infections, including HCV infections. In certain embodiments, compounds and compo sitions …

3′, 5′-cyclic phosphate prodrugs for HCV infection

CC Parsy, FR Alexandre, CB Dousson… - US Patent …, 2016 - Google Patents
(56) References Cited 8,618,076 B2 12/2013 Ross et al. 8,637.475 B1 1/2014 Storer et al.
US PATENT DOCUMENTS 8,642,756 B2 2/2014 Ross et al. 8,658,616 B2 2/2014 …

Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections

D Surleraux, CB Dousson, G Gosselin… - US Patent …, 2016 - Google Patents
3,480,613 A 11, 1969 Walton et al. 4.478, 749 A 10, 1984 Koster et al. 6,174,868 B1 1/2001
Anderson et al. 6,284.458 B1 9/2001 Anderson et al. 6,348,587 B1 2, 2002 Schinazi et al …

2′-chloro nucleoside analogs for HCV infection

G Gosselin, CC Parsy, FR Alexandre, H Rahali… - US Patent …, 2019 - Google Patents
Provided herein are compounds, compositions and methods for the treatment of Flaviviridae
infections, including HCV infections. In certain embodiments, compounds and compositions …

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

JP Sommadossi, A Moussa - US Patent 9,828,410, 2017 - Google Patents
7, 211, 570 B2 7, 268, 119 B2 7, 285, 658 B2 7, 307, 065 B2 7, 323, 449 B2 7, 339, 054 B2
7, 365, 057 B2 7, 384, 924 B2 7, 388, 002 B2 7, 429, 571 B2 7, 429, 572 B2 7, 456, 155 B2 …

3′-deoxy nucleosides for the treatment of HCV

AJ Stewart, AM Moussa, BA Mayes… - US Patent …, 2016 - Google Patents
Provided herein are compounds, compositions and methods for the treatment of Flaviviridae
infections, including HCV infections. In certain embodiments, compounds and compo sitions …

Substituted nucleosides, nucleotides and analogs thereof

LM Blatt, L Beigelman, JA Symons… - US Patent 10,307,439, 2019 - Google Patents
2017-03-10 Assigned to ALIOS BIOPHARMA, INC. reassignment ALIOS BIOPHARMA, INC.
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …